In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Myogen, Novartis Institutes in cardiovascular drug deal

Executive Summary

Myogen (small-molecule cardiovascular therapeutics) and the Novartis Institutes for Biomedical Research (an affiliate of Novartis AG) will collaborate on the discovery and development of new histone deacetylase inhibitors to treat cardiac hypertrophy and heart failure.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies